Nagasaki Dejima Illustration, drawn by KAWAHARA Keiga:owned by the Nagasaki University Library
Scroll
Topics
-
Publications 2025/3/27
-
Publications 2025/3/22
-
2025.3.10
Nagasaki University Secures CEPI Funding to Develop AI-Driven Nanoball Vaccine Technology – Targeting mRNA Vaccine for Severe Fever with Thrombocytopenia Syndrome (SFTS)
-
Visit from Sukraraj Tropical and Infectious Disease Hospital (STIDH), Kathmandu, Nepal
-
2024.11.13
Participation in Bio Japan 2024！
-
2025.3.10
Nagasaki University Secures CEPI Funding to Develop AI-Driven Nanoball Vaccine Technology – Targeting mRNA Vaccine for Severe Fever with Thrombocytopenia Syndrome (SFTS)
-
2025.3.5
Visit from Sukraraj Tropical and Infectious Disease Hospital (STIDH), Kathmandu, Nepal
-
2024.3.12
Nagasaki University signed an MOU with the International Vaccine Institute (IVI)
-
Nagasaki University held a launching ceremony for the DEJIMA Infectious Disease Research Alliance and the National Research Center for the Control and Prevention of Infectious Diseases.
-
2022.8.31
Nagasaki University Selected as One of the Vaccine Development Centers in Japan, aiming to Supply Vaccines within 100 Days of a Pandemic Outbreak: World-Leading R&D Center Program for Vaccine Development funded by AMED
-
2025.4.1
Publications 2025/3/27
-
2025.3.28
Publications 2025/3/22
-
2024.11.13
Participation in Bio Japan 2024！
-
2024.11.5
Vaccine Science Symposium and Short Course Held
-
2024.9.12
Exhibit at BioJapan 2024!